Explore Our Library of Biomanufacturing Resources & Technical Data

Application Notes

A Binding Advantage: Optibumin 25 Demonstrates Enhanced Drug Binding and Consistency over Plasma Albumin

High-Resolution Analytical Characterization of Optibumin®: Structural Homogeneity and Functional Consistency Compared to Plasma-Derived HSA

Low-DMSO Cryopreservation of MSCs with Optibumin 25 Recombinant Albumin

Maintaining Viable Cell Count in Primary T Cells During Cell Washing Using Optibumin®

Preserving Lentiviral Titer During Sterile Filtration Using Recombinant Albumin

Retain and Protect Final Cell Product with Optibumin®, a Recombinant Human Serum Albumin (rHSA)

Thiol by Combat: Enhanced Covalent Conjugation with Recombinant Albumin Compared to Human Plasma-Derived Albumin

Blog

Albumin in Drug Delivery: Cancer’s Unexpected Achilles’ Heel

Consistency Is the New Compliance

Evolving Challenges in Closed-System Biomanufacturing

How Regulatory Bodies Are Driving the Shift to Animal-Origin-Free Solutions in Cell Therapy and Vaccine Development

Innovative Solutions in Closed-System Biomanufacturing: Exploring the Tools and Technologies Driving Sterility and Efficiency

Optibumin vs Traditional Albumin: Comparing Performance in Cell Wash Applications

Scaling Innovation: How DiscGenics and InVitria are Leading the Future of Cell Therapy

Why Border Disruptions Threaten Blood-Derived Raw Materials—and What Biomanufacturers Can Do About It

Why Do Some Biologics Cross the Finish Line—While Others Crash and Burn?

Catalog

InVitria Product Catalog

Data Sheets

Optibumin 20 – Data Sheet

News

InVitria Launches Optibumin 25 rHSA

InVitria Showcases Exbumin and Optibumin 25 at IPEC Excipient World: Biologics Summit

Posters

Better Cells, Better Outcomes: Improving CAR-T Manufacturing with Animal-Free Cryopreservation and Wash Solutions

Enhanced Cryopreservation of Therapeutically Relevant Cells

Enhancing Cell Therapy Consistency and Safety

Recombinant Albumin Enhances Lentiviral Vector Stability During Downstream Processing

Recombinant Albumin Preserves Dilute Cytokine Recovery and Bioactivity at Room Temperature

Stronger Cells for Safer Therapies: Low-DMSO, Animal-Origin-Free T Cell Cryopreservation with Optibumin 25 and PentaHibe

Regulatory Documents

Certificate of Origin and Animal-Free / TSE-BSE Statement

cGMP Statement

ISO 9001:2015 Certificate of Registration

SDS

Optibumin 20 – Safety Data Sheet

Use Guidelines

Optibumin 20 – Guidelines for Use

White Papers

Emergence of Blood-Free Recombinant Human Albumin

Optimizing the Performance of LNP and Liposome Therapeutics with Blood-Free Recombinant Albumin